108 related articles for article (PubMed ID: 10098732)
21. Expression of p16(INK4A) induces dominant suppression of glioblastoma growth in situ through necrosis and cell cycle arrest.
Hung KS; Hong CY; Lee J; Lin SK; Huang SC; Wang TM; Tse V; Sliverberg GD; Weng SC; Hsiao M
Biochem Biophys Res Commun; 2000 Mar; 269(3):718-25. PubMed ID: 10720483
[TBL] [Abstract][Full Text] [Related]
22. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
Haviernik P; Schmidt M; Hu X; Wolff L
Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
[TBL] [Abstract][Full Text] [Related]
23. A retrovirus-based system to stably silence GDF-8 expression and enhance myogenic differentiation in human rhabdomyosarcoma cells.
Yang Z; Zhang J; Cong H; Huang Z; Sun L; Liu C; Tien P
J Gene Med; 2008 Aug; 10(8):825-33. PubMed ID: 18563849
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
Marampon F; Ciccarelli C; Zani BM
Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
[TBL] [Abstract][Full Text] [Related]
25. Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation.
Deneen B; Denny CT
Oncogene; 2001 Oct; 20(46):6731-41. PubMed ID: 11709708
[TBL] [Abstract][Full Text] [Related]
26. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution.
Grimison B; Langan TA; Sclafani RA
Cell Growth Differ; 2000 Oct; 11(10):507-15. PubMed ID: 11063124
[TBL] [Abstract][Full Text] [Related]
27. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
[TBL] [Abstract][Full Text] [Related]
28. Induction of apoptosis in p16INK4A mutant cell lines by adenovirus-mediated overexpression of p16INK4A protein.
Kim M; Katayose Y; Rojanala L; Shah S; Sgagias M; Jang L; Jung YJ; Lee SH; Hwang SG; Cowan KH
Cell Death Differ; 2000 Aug; 7(8):706-11. PubMed ID: 10918444
[TBL] [Abstract][Full Text] [Related]
29. Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.
Thompson PM; Maris JM; Hogarty MD; Seeger RC; Reynolds CP; Brodeur GM; White PS
Cancer Res; 2001 Jan; 61(2):679-86. PubMed ID: 11212268
[TBL] [Abstract][Full Text] [Related]
30. Effect of p16INK4a on chemosensitivity in nasopharyngeal carcinoma cells.
Chow LS; Wang X; Kwong DL; Sham JS; Tsao SW; Nicholls JM
Int J Oncol; 2000 Jul; 17(1):135-40. PubMed ID: 10853030
[TBL] [Abstract][Full Text] [Related]
31. P16INK4a expression adenovirus vector to suppress pancreas cancer cell proliferation.
Kobayashi S; Shirasawa H; Sashiyama H; Kawahira H; Kaneko K; Asano T; Ochiai T
Clin Cancer Res; 1999 Dec; 5(12):4182-5. PubMed ID: 10632358
[TBL] [Abstract][Full Text] [Related]
32. Loss of p16 protein expression associated with methylation of the p16INK4A gene is a frequent finding in Hodgkin's disease.
García JF; Villuendas R; Algara P; Sáez AI; Sánchez-Verde L; Martínez-Montero JC; Martínez P; Piris MA
Lab Invest; 1999 Dec; 79(12):1453-9. PubMed ID: 10616196
[TBL] [Abstract][Full Text] [Related]
33. Id1 is down-regulated by hepatocyte growth factor via ERK-dependent and ERK-independent signaling pathways, leading to increased expression of p16INK4a in hepatoma cells.
Ushio K; Hashimoto T; Kitamura N; Tanaka T
Mol Cancer Res; 2009 Jul; 7(7):1179-88. PubMed ID: 19567783
[TBL] [Abstract][Full Text] [Related]
34. [Exogenous mtsl/p16 gene suppresses tumorigenicity of human gastric cancer cell line].
Sun M; Lu Y
Zhonghua Zhong Liu Za Zhi; 1997 Nov; 19(6):410-3. PubMed ID: 10920869
[TBL] [Abstract][Full Text] [Related]
35. Effects of transforming growth factor beta 1 on the growth of rhabdomyosarcoma cell line RD.
Ye L; Zhang HY; Wang H; Yang GH; Bu H; Zhang L; Wang SL
Chin Med J (Engl); 2005 Apr; 118(8):678-86. PubMed ID: 15899124
[TBL] [Abstract][Full Text] [Related]
36. Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells.
Astolfi A; De Giovanni C; Landuzzi L; Nicoletti G; Ricci C; Croci S; Scopece L; Nanni P; Lollini PL
Gene; 2001 Aug; 274(1-2):139-49. PubMed ID: 11675006
[TBL] [Abstract][Full Text] [Related]
37. Ara-C treatment leads to differentiation and reverses the transformed phenotype in a human rhabdomyosarcoma cell line.
Crouch GD; Kalebic T; Tsokos M; Helman LJ
Exp Cell Res; 1993 Feb; 204(2):210-6. PubMed ID: 8440318
[TBL] [Abstract][Full Text] [Related]
38. p16INK4A promotes differentiation and inhibits apoptosis of JKB acute lymphoblastic leukemia cells.
Urashima M; DeCaprio JA; Chauhan D; Teoh G; Ogata A; Treon SP; Hoshi Y; Anderson KC
Blood; 1997 Nov; 90(10):4106-15. PubMed ID: 9354681
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of growth of human leukemia cell lines by retrovirally expressed wild-type p16INK4A.
Gombart AF; Yang R; Campbell MJ; Berman JD; Koeffler HP
Leukemia; 1997 Oct; 11(10):1673-80. PubMed ID: 9324288
[TBL] [Abstract][Full Text] [Related]
40. Aphidicolin induces myogenic differentiation in the human rhabdomyosarcoma cell line KFR.
Cinatl J; Cinatl J; Driever PH; Rabenau H; Novak M; Stefanik M; Kornhuber B; Doerr HW
Cell Biol Int; 1994 Apr; 18(4):271-8. PubMed ID: 8044142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]